翻訳と辞書 |
Sonidegib
Sonidegib (INN), also known as LDE225 and marketed as Odomzo, is a Hedgehog signaling pathway inhibitor (via smoothened antagonism) being developed as an anticancer agent by Novartis. ==Approvals and indications== It was approved by the FDA for treating basal cell carcinoma in July 2015〔 and is awaiting approval in the EU. In the EU, the agent has received positive opinion from the CHMP for approval.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Sonidegib」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|